Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $667.22M.
ENTERPRISE VALUE (EV)
$667.22M
Olema Pharmaceuticals, Inc.
Market Cap
$714.33M
Enterprise Value (EV)
$667.22M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | $714.33M | $667.22M |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $717.44M | $1.45B |
| Avalo Therapeutics, Inc. (AVTX)vs › | $719.59M | $634.45M |
| Cytek Biosciences, Inc. (CTKB)vs › | $720.94M | $673.55M |
| Achieve Life Sciences, Inc. (ACHV)vs › | $736.49M | $703.48M |
| Faeth Therapeutics, Inc. (FTH)vs › | $737.40M | $711.09M |
| Anteris Technologies Global Corp. (AVR)vs › | $689.73M | $435.66M |
| Candel Therapeutics, Inc. (CADL)vs › | $744.71M | $592.66M |
| Helus Pharma Inc. (HELP)vs › | $680.31M | $514.14M |
| Annexon, Inc. (ANNX)vs › | $677.49M | $502.87M |
Market Cap
$714.33M
Total Debt
$1.19M
Cash
$48.30M
Enterprise Value
$667.22M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
